• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$7.68 -$0.05 (-0.65%)

REAL-TIME: Last trade at

Accelrys, Inc.

NASDAQ:ACCL

Contur ELN from Accelrys Powers UK's Largest Trial of Academic Electronic Lab Notebooks

Accelrys Announces Purchase of Cloud-based HEOS Drug Discovery Information Management Technology from SCYNEXIS

Accelrys announces strategic collaboration with Thomson Reuters

Accelrys Announces Strategic Collaboration with Thomson Reuters

Accelrys Buys HEOS - Analyst Blog

Accelrys Buys HEOS

Accelrys buys cloud-based HEOS technology from SCYNEXIS

Accelrys Announces Purchase of Cloud-based HEOS Drug Discovery Information Management Technology from SCYNEXIS

Accelrys Announces Purchase of Cloud-based HEOS Drug Discovery Information Management Technology from SCYNEXIS

Global Bioinformatics Industry

Accelrys to hold a user group meeting

Accelrys, Inc. (ACCL) Tops Q1 EPS by 2c; Guides FY12 EPS, Revs

Accelrys sees FY adjusted EPS 32c-34c, consensus 33c

Accelrys reports Q1 EPS 8c, consensus 6c

Accelrys Announces May 2012 North American User Group Meeting Co-Located With IMACS

Accelrys to Announce First Quarter 2012 Results on May 3, 2012

BT for Life Sciences R&D: The Cloud for Accelerated Discovery

BT for Life Sciences R&D: The Cloud for Accelerated Discovery

Accelrys Discussing Productivity Gap

Accelrys Challenges Industries to Speed Innovation by Transforming the Scientific Innovation Lifecycle

Feltl & Co Starts Accelrys (ACCL) at Buy

Accelrys initiated with a Buy at Feltl

Accelrys management to meet with B. Riley

Accelrys to Present at Sidoti Sixteenth Annual New York Institutional Investor Forum on March 20, 2012

Accelrys Expects Business Investments to Bear Fruit, Encourage Growth in 2012

Accelrys sees FY12 EPS 32c-34c, consensus 32c

Accelrys reports Q4 EPS 8c, consensus 7c

Accelrys Posts 27 Percent Q4 Revenue Growth

Accelrys Announces Fourth Quarter and Full Year 2011 Financial Results

Accelrys Works with Oxford Nanopore to Prep Analysis Tools for Upcoming GridIon, MinIon

Accelrys Announces Date of Fourth Quarter and Full Year 2011 Financial Results Conference Call

INFORMATION TECHNOLOGY Accelrys acquires drug lab software specialist VelQuest

Accelrys Buys VelQuest for $35M to Tap Into Market for Regulatory Compliance Software

Accelrys Acquires Massachusetts Company for $35M

Westborough Firm Bought For $35M

Accelrys buys privately held VelQuest for $35 M

Accelrys (ACCL) Acquires VelQuest Corp. in $35M Cash Deal

Accelrys acquires VelQuest for $35M in cash

Accelrys Acquires VelQuest Corporation for $35 Million in Cash

Craig-Hallum Starts Accelrys (ACCL) at Buy

See More Articles...